DEBORAH CLAREY: Open Payments
NPI 1427030980 · ONEIDA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,338 in 75 payments from 18 companies in 2025. Trend: 2023 $1,829 · 2024 $1,992 · 2025 $2,338
Food & beverage: $2,338
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $346 |
| PFIZER INC. | 17 | $240 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $235 |
| Lilly USA, LLC | 5 | $190 |
| Axsome Therapeutics, Inc. | 5 | $185 |
| Novo Nordisk Inc | 5 | $161 |
| Phathom Pharmaceuticals, Inc. | 3 | $145 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $145 |
| Radius Health, Inc. | 1 | $141 |
| ABBVIE INC. | 6 | $124 |
Products named: BREZTRI, CAPLYTA, Auvelity, NURTEC ODT, VOQUEZNA, XIFAXAN, Tymlos, ZEPBOUND.
Industry payments across NY — which companies pay providers there.
